Cambridge Epigenetix is based in Cambridge, Country. It has raised $146M in total funding. Latest round: Series D. Backed by Temasek, Third Point, GV.
Cambridge Epigenetix is based in Cambridge, Country. Cambridge Epigenetix has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in November 2021. The round record for Cambridge Epigenetix runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Third Point, GV, New Science Ventures, Ahren Innovation Capital, Sequoia. 6 distinct backers are named across the disclosed rounds.
We update the Cambridge Epigenetix record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026